我武生物跌2.02%，成交额3554.66万元，主力资金净流出9.88万元

Core Points - The stock price of Iwu Biotech has increased by 71.09% year-to-date, but has seen a recent decline of 2.58% over the last five trading days [2] - The company reported a revenue of 853 million yuan for the period from January to September 2025, representing a year-on-year growth of 16.86%, and a net profit of 345 million yuan, up 26.67% [2] - Iwu Biotech's main business revenue is primarily derived from dust mite drops (94.17%), followed by other products such as Artemisia annua flowers (4.35%) and skin prick liquid (1.31%) [2] Financial Performance - As of September 30, 2025, Iwu Biotech has a market capitalization of 18.006 billion yuan, with a trading volume of 35.5466 million yuan and a turnover rate of 0.21% [1] - The company has distributed a total of 913 million yuan in dividends since its A-share listing, with 317 million yuan distributed over the past three years [3] Shareholder Information - The number of shareholders as of September 30, 2025, is 32,400, a decrease of 6.22% from the previous period, while the average circulating shares per person increased by 6.63% to 14,927 shares [2] - Major shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 1.4524 million shares, and new entrants such as Harvest Mutual Fund [3]